Boehringer Ingelheim acquires Global Stem cell Technology
Boehringer Ingelheim acquires Global Stem cell Technology, Belgian veterinary biotech company, to strengthen its stem cell capabilities in Animal Health
Societal challenges require collective action and Making More Health Together is connecting changemakers to drive collaborations for more social impact